Quoin Pharmaceuticals Ltd. ADR Stock
The community is currently still undecided about Quoin Pharmaceuticals Ltd. ADR with 1 Buy predictions and 0 Sell predictions.
With a target price of 3 € there is potential for a 508.52% increase which would mean more than doubling the current price of 0.49 € for Quoin Pharmaceuticals Ltd. ADR.
Our community identified positive and negative aspects for Quoin Pharmaceuticals Ltd. ADR stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Quoin Pharmaceuticals Ltd. ADR stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Quoin Pharmaceuticals Ltd. ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quoin Pharmaceuticals Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd. ADR | - | - | - | - | - | - | - |
| Medpace Holdings Inc | 1.180% | 0.523% | -0.164% | 96.344% | 29.964% | 160.857% | - |
| Galapagos N.V. | -2.190% | 1.193% | -7.435% | -25.234% | -26.728% | -58.220% | - |
| Taro Pharmaceutical Industries Ltd | - | -0.505% | 1.026% | 69.828% | 4.787% | -35.935% | -58.618% |
Comments
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) had its price target lowered by analysts at Maxim Group from $15.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for QNRX provided by MarketBeat